• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
X0406758 拉莫三嗪片 lamotrigine Tablet Chemical Drugs Supplementary Application 2004-11-17 桂林三金集团湖南三金制药有限责任公司 Sanjin Group Hunan Sanjin Pharmaceutical Co Ltd;Tianjin Remedy Research Institute Certificate Issued 2005-03-21 view
X0406757 拉莫三嗪 lamotrigine Active ingredient Chemical Drugs Supplementary Application 2004-11-17 桂林三金集团湖南三金制药有限责任公司 Sanjin Group Hunan Sanjin Pharmaceutical Co Ltd;Tianjin Remedy Research Institute Certificate Issued 2005-03-21 view
JYHZ2200151 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs License Renew 2022-06-17 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA view
JYHZ2200150 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) License Renew 2022-06-17 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA view
JYHZ2200149 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) License Renew 2022-06-17 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA view
JYHZ2200148 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) License Renew 2022-06-17 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA view
JYHZ2200147 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs(5.1) License Renew 2022-06-17 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA view
JYHZ2100051 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2021-03-11 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA Certificate Issued 2021-10-19 view
JYHZ2100050 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2021-03-11 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA Certificate Issued 2021-10-19 view
JYHZ1700012 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs License Renew 2017-07-26 泰卫医药信息咨询(上海)有限公司 Teva Pharmaceutical Information Consulting (Shanghai) Co Ltd;Actavis Group Ptc Ehf Certificate Issued 2018-07-19 view
JYHZ1700011 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs License Renew 2017-08-03 泰卫医药信息咨询(上海)有限公司 Teva Pharmaceutical Information Consulting (Shanghai) Co Ltd;Actavis Group Ptc Ehf Certificate Issued 2018-07-19 view
JYHZ1600068 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2016-03-08 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA Certificate Issued 2016-12-01 view
JYHZ1600067 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2016-03-17 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA Certificate Issued 2016-12-01 view
JYHZ1500326 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2015-10-08 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA Certificate Issued 2016-12-01 view
JYHZ1500325 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2015-10-08 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA Certificate Issued 2016-12-01 view
JYHB2500231 拉莫三嗪片 lamotrigine Tablet Chemical Drugs Supplementary Application 2025-04-22 The Wellcome Foundation Ltd;Delpharm Poznan SA view
JYHB2500230 拉莫三嗪片 lamotrigine Tablet Chemical Drugs Supplementary Application 2025-04-22 The Wellcome Foundation Ltd;Delpharm Poznan SA view
JYHB2500228 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2025-04-19 The Wellcome Foundation Ltd;Delpharm Poznan SA view
JYHB2400625 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2024-11-30 The Wellcome Foundation Ltd;Delpharm Poznan SA view
JYHB2400624 拉莫三嗪分散片 lamotrigine Tablet Chemical Drugs Supplementary Application 2024-11-30 The Wellcome Foundation Ltd;Delpharm Poznan SA view